Quantifying the efficiency of siRNA-induced gene silencing is essential for validating RNA interference (RNAi) experiments and ensuring the specificity and effectiveness of gene knockdown. Two gold-standard methods used for assessing knockdown levels are quantitative reverse transcription PCR (qRT-PCR), which measures mRNA abundance, and Western blotting (WB), which detects corresponding protein levels. Together, these complementary techniques provide a robust framework for confirming the success of siRNA-mediated gene silencing at both the transcript and protein expression levels.
qRT-PCR: Measuring mRNA Knockdown
Quantitative reverse transcription PCR (qRT-PCR) is a sensitive and precise method used to evaluate the depletion of target mRNA following siRNA transfection. The process involves isolating total RNA from transfected cells, reverse-transcribing the RNA into complementary DNA (cDNA), and amplifying specific gene transcripts using fluorescently labeled primers or probes.
Target gene expression is quantified relative to one or more housekeeping genes (such as GAPDH or ACTB), which serve as internal controls for normalization. The relative expression is typically calculated using the ΔΔCt method, which allows comparison between siRNA-treated and control groups. Effective knockdown is generally indicated by a ≥70% reduction in target mRNA levels.
Several variables can influence the accuracy of qRT-PCR, including RNA integrity, primer efficiency, reverse transcription yield, and siRNA sequence specificity. Proper experimental controls, such as non-targeting siRNA and no-template reactions, are essential to confirm specificity and eliminate background signals.
Western Blot: Assessing Protein Knockdown
Western blotting is used to verify the downstream effect of siRNA treatment on protein expression. Since mRNA degradation does not always result in equivalent protein depletion—due to differences in protein half-life or translational regulation—Western blotting provides critical confirmation of functional knockdown.
The procedure involves lysing siRNA-treated cells, resolving proteins by SDS-PAGE, transferring them to a membrane, and probing with antibodies specific to the target protein. Detection is achieved through chemiluminescent or fluorescent signals. Quantitative analysis is performed by densitometry, often normalized to a housekeeping protein (e.g., β-actin or tubulin) to control for loading differences.
Western blotting is especially valuable when the target gene product is involved in phenotypic assays, as it establishes a direct link between knockdown and cellular response. However, antibody specificity and signal linearity must be validated to ensure reliable quantification.
Complementary Use and Interpretation
qRT-PCR and Western blotting are most informative when used together. qRT-PCR enables rapid screening of knockdown across multiple siRNA candidates, while Western blotting provides confirmation at the functional protein level. Discordance between mRNA and protein knockdown may indicate post-transcriptional regulation, low protein turnover, or off-target effects.
To ensure experimental rigor, both techniques should include technical replicates, appropriate negative controls (e.g., scrambled siRNA), and untreated samples. Validated primer sets, high-quality antibodies, and optimized reaction conditions contribute to the reproducibility and interpretability of results.
Applications in RNAi Research
These quantification methods are indispensable for validating siRNA transfections in basic and applied research. They are routinely used in studies of gene function, disease modeling, pathway mapping, drug screening, and biomarker identification. In high-throughput workflows, qRT-PCR is particularly suited for parallel analysis of multiple targets, while Western blotting remains the standard for confirming biologically relevant knockdown at the protein level.
Altogen Labs siRNA Knockdown Validation Services
Altogen Labs offers comprehensive RNAi validation services, including qRT-PCR and Western blot analysis, to support precise quantitation of siRNA-induced gene knockdown. Their end-to-end workflow includes RNA and protein extraction, primer and antibody selection, and data interpretation with statistical rigor.
Altogen Labs employs optimized transfection protocols and high-sensitivity detection platforms to ensure reliable results across diverse cell types and experimental models. Researchers benefit from detailed validation reports that confirm siRNA efficacy and support downstream functional studies.
More information about knockdown validation services is available at Altogen Labs.